Starting Wednesday, anybody aged 65 years old or over who tests positive using a COVID-19 rapid test will be eligible for the oral antiviral drug Paxlovid if their result is confirmed by a doctor, according to the Central Epidemic Command Center (CECC).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan plans to expand free hepatitis screening program
04/12/2025 06:57 PM - Business
Measures to curb stock short selling prolonged into next week
04/12/2025 05:47 PM - Business
- Politics
Prosecutors seek detention of 5 staffers at DPP lawmaker's offices
04/12/2025 05:00 PM - Politics
Ex-assistant of foreign minister detained as spying cases in DPP expand
04/12/2025 04:49 PM